Xcout IntelANCORA HEART, INC.
Ancora Heart, Inc. is a medical device and equipment manufacturing company headquartered in Santa Clara, California, focused on treatments for heart failure.
Subscribe to see ANCORA HEART, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ANCORA HEART, INC. at a glance
ANCORA HEART, INC. is a healthcare company headquartered in United States, founded in 2001. It has raised at least $139.1M across the 4 funding rounds on record. Its most recent funding round, Equity Financing, raised $80M in June 2021. Xcout tracks 12 named people at ANCORA HEART, INC., including Jeffrey M. Closs (PRESIDENT AND CEO).
ANCORA HEART, INC. leadership
- Jeffrey M. ClossPRESIDENT AND CEO
- Russel SampsonCHIEF TECHNICAL OFFICER
- Mark MilesCHIEF COMMERCIAL OFFICER
- Bart BeasleyVICE PRESIDENT OF STRATEGIC INITIATIVES
- Christine TjossemVICE PRESIDENT OF BIOSTATISTICS AND CLINICAL DATA MANAGEMENT
- Linda Phan LuVICE PRESIDENT FINANCE, HUMAN RESOURCES AND ADMINISTRATIVE SERVICES
6 more named people on record for ANCORA HEART, INC., with roles, board committees and tenure — see the full roster →
ANCORA HEART, INC. funding rounds
At least $139.1M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Equity Financing | $80M | 3 named | |
| Equity Financing | $17.8M | 2 named | |
| SEC Form D filing | $23.5M | — | |
| — | $17.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
ANCORA HEART, INC. competitors
A few of ANCORA HEART, INC.'s closest competitors — see the full list of competitors and alternatives →
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Cortex, Inc. is a medical technology company based in Menlo Park, California. The company specializes in the medical device sector, focusing specifically on innovative products for the diagnosis and treatment of atrial arrhythmias.
Scandinavian Real Heart develops the Realheart TAH, a total artificial heart designed to save lives and improve the quality of life for patients with severe heart failure. The medical technology company primarily serves cardiac patients requiring surgical heart replacement solutions.
Innoventric is a medical device company founded in 2016 and headquartered in Rehovot, Israel, dedicated to addressing the complexities of tricuspid regurgitation with transcatheter solutions.
Ichor Vascular, Inc. is a medical device company developing advanced arterial and venous solutions to bridge clinical gaps in thrombectomy technologies. Headquartered in Boca Raton, Florida, the firm innovates surgical tools for vascular treatments.
CorAssist Cardiovascular Ltd. was a clinical-stage medical device company based in Haifa, Israel, focused on developing therapeutic products for treating heart failure with preserved ejection fraction and diastolic heart failure. The company ceased operations in December 2022.
Get ANCORA HEART, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ANCORA HEART, INC. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access